Since increased CCL5 expression predominates in the M-GBM molecular subtype and mouse Nf1-deficient GBM cells exhibit reduced growth following Ccl5 KD, we tested the hypothesis that the NF1 protein (neurofibromin) function is responsible for regulating Ccl5 expression. The gene discussed is NF1; the disease is glioblastoma.